News Ticker

WIRE: Legal cannabis markets grow in the U.S. and globally

NEW YORK — Legal cannabis sales in the United States are projected to hit $21.8 billion by 2020 assuming a compound annual growth rate of 25% according to Arcview Market Research.

This is based on the North American cannabis sales in 2016, which grew by an unprecedented 30% to $6.7 billion as the legal market expands.

Tom Adams, Arcview’s editor-in-chief, commented, “The only consumer industry categories I’ve seen reach $5 billion in annual spending and then post anything like 25% compound annual growth in the next five years are cable television (19%) in the 1990’s and the broadband internet (29%) in the 2000’s.” (OTC: CIIX), United Cannabis Corporation (OTC: CNAB), Vitality Biopharma Inc. (OTC: VBIO), Cannabis Sativa Inc. (OTC: CBDS) Eco Science Solutions Inc. (OTC: ESSI)

North America is not the only country where the perception towards cannabis products is becoming more acceptable. The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of countries legalizing the use of medical marijuana in various parts of the world is one of the key factors driving the usage rate of cannabis in various therapeutic applications, such as pain management, appetite enhancement, and reducing eye pressure. (OTCQB: CIIX) announced earlier in February that, “the launch of its new website for its new subsidiary The website went live on January 31st under the URL: . The Company is expanding into the medical marijuana industry with the launch of its website and plans to retail hemp oil and related products, which are legal to sell and distribute within China and in the United States in all fifty states (hemp oil is not marijuana, but indeed a separate and distinct plant made from hemp). CBD oil, derived from hemp is a product with medicinal qualities that are primarily used for anti-inflammatory and other common ailments. Its website is intended for the Chinese speaking population, a global market of 2 Billion people.”

Our expertise in online communications with our background in media, technology, and journalism, via our website will further enhance our success. Our core business, the online distribution of news to the Chinese speaking population about financial markets and stocks has been a very solid and consistently robust business for our shareholders. Now as we expand into online retailing and distribution of CBD oils to the Chinese speaking population with a focus on hemp and medicinal needs via consumer products. This will create a much needed and growing niche for us to enter. Indeed, we believe we are the first public company to enter this market in China.”

United Cannabis Corporation (OTCQB: CNAB) Prana Bio Medicinal products provide patients a simple, safe, accurate, and easy way to mix match cannabinoids for therapeutic purpose. These products are broken into 5 easy to use categories that are available in capsules, sublinguals, and topical delivery methods. The company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability. Prana Bio Medicinal products are NON-GMO, ethanol free, alcohol free, glycerin free, gluten free, 100% naturally derived, chemical-free, solventless, and hypoallergenic.

Vitality Biopharma Inc. (OTCQB: VBIO), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals and applies cannabinoids for the treatment of serious neurological and inflammatory disorders, announced that it has created a library of proprietary glycosides of THC (delta-9-tetrahydrocannabinol), the main psychoactive chemical found in cannabis or marijuana, which enable targeted delivery that reduces or eliminates psychoactivity when used in oral drug formulations. “This new drug opens up novel opportunities for treatment of pain and inflammation,” said Dr. Brandon Zipp, Director of R&D at Vitality. “We can now exploit the cannabinoid receptor system without systemic THC that compromises cognitive function.” Robert Brooke, CEO of Vitality, adds that, “It is THC without the high and could be a game changer, especially for treatment of indications like Crohn’s disease and for use in children.”

Cannabis Sativa Inc. (OTCQB: CBDS) announced that its new Ibudtender app will be ready for beta testing. The app will hold the highest health and safety standards for consumers to date. “The Ibudtender team has been working hard to complete what will be the most sophisticated app in the space”, said David Tobias, President of Cannabis Sativa. “The beta test will give the technology a chance to perform, interact with users, get analyzed and perfected, and a final release to follow quickly.” Ibudtender is accepting applications from select consumers for this project. Ibudtender is also accepting a limited number of dispensaries, delivery services and manufacturers to test its new state of the art business software.

Eco Science Solutions Inc. (OTCQB: ESSI) owns the application, Herbo. Herbo are growers, users, and beneficiaries of cannabis. The app was made to help users find medical cannabis dispensaries, smoke shops, legal doctors, clinics, and delivery services in specific areas, but also wants to help users ingest cannabis the best possible ways. So they partnered with the largest and best paraphernalia manufacturers and distributors to bring awesome products at great prices.

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. “The Latest Buzz in Financial News”

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

Leave a comment